Shares of major cannabis companies experienced a significant rally on Thursday following a landmark decision by the United States government to reclassify marijuana as a less dangerous substance. This shift in federal policy is being hailed by industry experts as one of the most significant regulatory developments in decades.
US Moves to Reclassify Marijuana as Schedule III Drug
The Department of Justice is moving marijuana from Schedule I to Schedule III. This shift allows cannabis firms to claim tax deductions and access bank funding.
Xurve View
Insights:
Xurve View












